1. Arakawa, T., Philo, J.S., 2002. Biophysical and biochemical analysis of recombinant proteins. In: Crommelin, D.J.A., Sindelar, R.D. (Eds.), Pharmaceutical Biotechnology. Taylor & Francis, London, pp. 25–52.
2. Current guidelines for the preclinical safety assessment of therapeutic proteins;Bass;Toxicol. Lett.,1992
3. Biotechnology Industry Organization Site, 2002. http://www.bio.org/er/statistics.asp.
4. Braeckman, R., 2002. Pharmacokinetics and pharmacodynamics of peptide and protein drugs. In: Crommelin, D.J.A., Sindelar, R.D. (Eds.), Pharmaceutical Biotechnology. Taylor & Francis, London, pp. 105–131.
5. Preclinical safety testing of biotechnology-derived pharmaceuticals;Cavagnaro;Nat. Rev. Drug Disc.,2002